Discontinued — last reported Q2 '22
Long-Term Taxes Payable
Non-Current LiabilitiesEli Lilly Long-Term Taxes Payable decreased by 6.7% to $5.88B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 44.7%, from $4.06B to $5.88B. Over 5 years (FY 2020 to FY 2025), Long-Term Taxes Payable shows an upward trend with a 8.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ3 2019
Last reportedQ2 2022
How to read this metric
Significant changes often relate to shifts in international tax laws, changes in corporate tax rates, or the resolution of tax audits.
Detailed definition
Tax obligations that are not expected to be settled within the next year, often including deferred tax liabilities or re...
Peer comparison
Multinational tech companies often have complex long-term tax liabilities due to intellectual property shifting and global minimum tax regulations.
Metric ID:
long_term_taxes_payableHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.74B | $3.77B | $3.92B | $3.98B | $3.56B | $3.64B | $3.71B | $3.84B | $3.33B | $3.47B | $3.85B | $4.19B | $3.50B | $3.88B | $4.06B | $5.37B | $5.68B | $6.29B | $5.88B |
| QoQ Change | — | +0.8% | +4.0% | +1.5% | -10.6% | +2.4% | +1.9% | +3.6% | -13.3% | +4.1% | +11.0% | +8.8% | -16.5% | +10.9% | +4.7% | +32.2% | +5.8% | +10.7% | -6.7% |
| YoY Change | — | — | — | — | -4.8% | -3.4% | -5.4% | -3.4% | -6.4% | -4.8% | +3.8% | +9.0% | +5.0% | +11.8% | +5.5% | +28.2% | +62.6% | +62.3% | +44.7% |
Range$3.33B – $6.29B
CAGR+10.6%
Avg YoY Growth+13.6%
Median YoY Growth+5.0%
Long-Term Taxes Payable at Other Companies
Frequently Asked Questions
- What is Eli Lilly's long-term taxes payable?
- Eli Lilly (LLY) reported long-term taxes payable of $5.88B in Q4 2025.
- How has Eli Lilly's long-term taxes payable changed year-over-year?
- Eli Lilly's long-term taxes payable increased by 44.7% year-over-year, from $4.06B to $5.88B.
- What is the long-term trend for Eli Lilly's long-term taxes payable?
- Over 5 years (2020 to 2025), Eli Lilly's long-term taxes payable has grown at a 8.9% compound annual growth rate (CAGR), from $3.84B to $5.88B.
- What does long-term taxes payable mean?
- Taxes the company expects to pay in the future, but not within the next twelve months.